| Institution: | 1. Institute for Genome Sciences and Policy, Center for Human Genome Variation, Duke University, Durham, NC 27710, USA;2. Department of Biology, Duke University, Durham, NC 27710, USA;3. Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA;4. The Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital East, Charlestown, MA 02129, USA;5. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA;6. Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD 21702, USA;7. Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA;8. Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA;9. Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA;10. Program in Medical and Population Genetics and Genetic Analysis Platform, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;11. Division of Genetics, Department of Medicine, Brigham and Women''s Hospital, Harvard Medical School, Boston, MA 02215, USA;12. Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA;13. Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK;14. Division of Retrovirology, Walter Reed Army Institute of Research, 1600 East Gude Drive, Rockville, MD 20850, USA;15. Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20307, USA |
